India Plasma Fractionation Market Size, Share, Global Trends, Major Key Players and Geographical Forecast Till 2028

Posted on Aug 4 2022 5:42 AM

"Key Prominent Players Covered in the India Plasma Fractionation Market are PlasmaGen BioSciences Pvt. Ltd. (Bangalore, India), Reliance Life Sciences (Mumbai, India), Biocon Limited (Bangalore, India), Intas Pharmaceuticals Ltd. (Ahmedabad, India), Bharat Serums and Vaccines Limited (BSV) (Mumbai, India), VIRCHOW BIOTECH (Hyderabad, India), Fusion Healthcare (Hyderabad, India), Kedrion S.p.A (Barga, Italy), Hemarus (Hyderabad, India)"

The India plasma fractionation market size is anticipated to hit USD 470.6 million by 2030 and exhibit a CAGR of 4.2% during the forecast period. The growing prevalence of immune-deficiency disorders and the expanding geriatric population are expected to be the key factors driving the market growth. Fortune Business InsightsTM has presented this information in its report titled, “India Plasma Fractionation Market, 2021-2030”. The market size stood at USD 331.7 million in 2020 and USD 326.3 million in 2021.

Get Sample Report:

Drivers & Restraints-

Growing Prevalence of Immune-Deficiency Disorders to Fuel Market Growth

The increasing prevalence of immune-deficiency disorders is expected to boost plasma protein adoption across India, which, in turn, is anticipated to surge the demand for plasma fractionation. Additionally, the coronavirus pandemic has struck India immensely. The high number of hospitalizations and unprecedented demand for plasma have provided significant traction to the market.

The rising demand for coagulation factors is projected to benefit the market. Coagulation factors are proteins present in plasma that aid in bleeding disorder treatment. A large number of cases of hemophilia has been observed in recent years, and the numbers are expanding. Therefore, this is expected to magnify the India plasma fractionation market share. However, the low availability of plasma domestically may hinder the market growth during the forecast period.

Product, Application, and End-User are Studied

On the basis of product, the market is segmented into coagulated factors, immunoglobulins, albumin, and others. On the basis of application, the market is fragmented into pulmonology, critical care, hematology, immunology & neurology, and others. On the basis of end-user, the market is classified into research organizations, hospitals & clinics, and others.

Available Customizations

With the given market data, Fortune Business Insights offers customizations as per the company’s specific requirements. The following customization options are available for the report:

Product Analysis

  • Product matrix provides detailed product information and comparison

Geographic Analysis

  • Further breakdown of the North American India Plasma Fractionation Market
  • Further breakdown of the European market
  • Further breakdown of the APAC market
  • Further breakdown of the MEA market
  • Further breakdown of the Latin American market

Company Information

  • Detailed analysis and profiling of additional market players

Purchase Full Report at -

Primary Research:

Various sources from both the supply and demand sides were interviewed during the primary research process to obtain qualitative and quantitative information for this report. Primary sources included industry experts from the core and related industries, as well as preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations from all segments of the value chain of this industry. To obtain and verify critical qualitative and quantitative information, in-depth interviews were conducted with a variety of primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants.

Major India Plasma Fractionation Market Manufacturers covered in the market report include:

  • PlasmaGen BioSciences Pvt. Ltd. (Bangalore, India)
  • Reliance Life Sciences (Mumbai, India)
  • Biocon Limited (Bangalore, India)
  • Intas Pharmaceuticals Ltd. (Ahmedabad, India)
  • Bharat Serums and Vaccines Limited (BSV) (Mumbai, India)
  • VIRCHOW BIOTECH (Hyderabad, India)
  • Fusion Healthcare (Hyderabad, India)
  • Kedrion S.p.A (Barga, Italy)
  • Hemarus (Hyderabad, India)

Table Of Content:

  • India Plasma Fractionation Market Analysis, Insights and Forecast, 2017-2030
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Product
      • Albumin
      • Immunoglobulin
      • Coagulation Factors
        • Factor VIII
        • Factor IX
        • Others
      • Others
    • Market Analysis, Insights and Forecast – By Application
      • Immunology & Neurology
      • Hematology
      • Critical Care
      • Pulmonology
      • Others
    • Market Analysis, Insights and Forecast – By End-user
      • Hospitals & Clinics
      • Research Organizations
      • Others
    • Competitive Analysis
      • India Market Share Analysis (2020)
      • Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
        • PlasmaGen
        • Reliance Life Sciences
        • Biocon Limited
        • Intas Pharmaceuticals Ltd.
        • Bharat Serums and Vaccines Limited (BSV)
        • Hemarus
        • Kedrion S.p.A
        • Fusion Healthcare

Ask for Customization of this Report:

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.


Fortune Business Insights Pvt. Ltd.9th Floor, Icon Tower, Baner –

Mahalunge Road, Baner, Pune-411045,

Maharashtra, India.


US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: [email protected]

LinkedIn Facebook Twitter